🔎 Trials Near Me

Gara Jalqabaatti › Myelofibrosis › Maryland

Qorannoo klinikaalii Myelofibrosis Maryland keessatti

Qorannoo 9 Myelofibrosis f Maryland keessatti hirmaatuu jiru.

Magaalota Maryland keessatti

Takkalaa qorannoo (Ingiliffa)

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06398457

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  • University of Maryland, Baltimore
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04176198

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

  • American Oncology Partners PA Center for Cancer and Blood Disorders, Bethesda
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07357727

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Johns Hopkins University, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  • John Hopkins Hospital, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

  • Johns Hopkins Hospital, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06034002

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

  • Maryland Oncology Hematology - Independent of SCRI/ US Oncology, Columbia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Gur-2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Bethesda
  • Massive Bio SYNERGY-AI site, Silver Spring
  • fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
  • The Center for Cancer and Blood Disorders, Bethesda
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2025 · NCT06479135

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.